Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
MTVA
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comNEGATIVO
Sector Update: Healthcare Stocks Softer Late Afternoon
Healthcare stocks were lower late Thursday afternoon, with the NYSE Healthcare Index shedding 0.5% a PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
OTC Markets Life Sciences Investor Forum: MetaVia CEO HH Kim and CFO Marshall Woodworth with Zacks SCR's David Bautz
NASDAQ: MTVA Greg Young: Hello and welcome to the Life Sciences Investor Forum. On behalf of OTC Markets and our co-host, Zacks Small Cap Research, we are very pleased you have joined us. The first presentation of the day is from MetaVia.…
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the June 24th & 25th Life Sciences Virtual Investor Forum are now availabl…
Presenting on Emerging Growth Conference 93 Day 1 on June 10; Register to live stream
Emerging Growth MIAMI, June 09, 2026 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 93rd Emerging Growth Conference on June 10 & 11, 2026. The Emerging Growth Conference id…
Top Biotech Gainers: AKTX Rallies; GOVX Up On Ebola Concerns; SLGL Awaits Catalysts; CMMB On Watch
(RTTNews) - Biotech stocks witnessed strong momentum on Friday, with Akari Therapeutics leading the pack, driven by encouraging preclinical pancreatic cancer data for AKTX-101. MetaVia, GeoVax, Polyrizon, and Sol-Gel were also some of the…
MTVA Gains Weight, CODX Takes A Shot At Ebola, EDSA To Reveal New Data, BDTX On Watch
(RTTNews) - As hedge fund tycoon George Soros once said, "It's not whether you're right or wrong that's important, but how much money you make when you're right and how much you lose when you're wrong." The following biotech stocks were am…
Sector Update: Healthcare Stocks Gain Late Afternoon
Healthcare stocks rose late Tuesday afternoon, with the NYSE Healthcare Index and the State Street H PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Healthcare stocks rose Tuesday afternoon, with the NYSE Healthcare Index adding 1.1% and the State S PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
Virtual Investor Conferences NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that presentations from the Life Sciences Virtual Investor Forum, h…
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that presentations from the Life Sciences Virtual Investor Forum, held March 11th – 12th, are no…
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
Virtual Investor Conferences Company Executives Share Strategic Vision and Engage with Investors Live at VirtualInvestorConferences.com NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary inve…
MetaVia's Obesity Drug Posts Strong Early Weight-loss Results
(RTTNews) - MetaVia Inc. (MTVA) said Monday its experimental obesity drug delivered statistically significant weight loss and metabolic improvements in an early-stage study, bolstering investor optimism around its pipeline. The clinical-st…
MetaVia Regains Compliance with Nasdaq Minimum Bid Price Requirement
CAMBRIDGE, Mass., Dec. 22, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that on December 19, 2025, it received formal notice from…
MetaVia Inc. Announces 1-for-11 Reverse Stock Split
CAMBRIDGE, Mass., Dec. 2, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA) ("MetaVia" or the "Company"), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced a 1-for-11 reverse stock spli…
The US market regular session of Tuesday is over, let's have a look at the top gainers and losers in the after hours session today. [postmarket] TODAY'S AFTER HOURS GAINERS TICKER CHANGE COMMENT SPRC [https://www.chartmill.com/stock/quote/…
These stocks are moving in today's pre-market session
The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. [premarket] TODAY'S PRE-MARKET GAINERS TICKER CHANGE COMMENT BGI [https://www.chartmill.com/stock/quote…
Monday's after hours session: top gainers and losers
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. [postmarket] GAINERS TICKER CHANGE COMMENT WBTN [https://www.chartmill.com/stock/quote/WBTN/profile] 71.66% After the regular…
* MetaVia (NASDAQ:MTVA [https://seekingalpha.com/symbol/MTVA]) registers 14.08M common shares for potential resale by selling securityholders. * Shares include 9.48M issued in a May 8, 2025 private placement agreement. * An additional 4.6M…
MetaVia Presents Pre-Clinical Data on DA-1241 Demonstrating Additive Hepatoprotective Effects in Combination With Efruxifermin at the ADA's 85th Scientific Session
CAMBRIDGE, Mass., June 21, 2025 /PRNewswire/ -- MetaVia Inc.(Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced the presentation of pre-clinical data on DA-1241, a novel…
Life Sciences Investor Forum: Now Available for Online Viewing
Virtual Investor Conferences Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference…
Life Sciences Investor Forum: Now Available for Online Viewing
NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Sciences Investor Forum, held June 11th and 12th are now availabl…
Life Sciences Investor Forum Agenda Announced for June 11th-12th
Virtual Investor Conferences Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference…
Life Sciences Investor Forum Agenda Announced for June 11th-12th
NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the Life Sciences Investor Forum June 11th & 12th. This event is co-hosted by Zacks Small…
MetaVia to Present at the Life Sciences Virtual Investor Forum June 12th
CAMBRIDGE, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that Hyung Heon Kim, President and Chief Executive Of…
Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream
MIAMI, May 21, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 82nd Emerging Growth Conference on May 21 & 22, 2025. The Emerging Growth Conference identifies companies…
Presenting on Emerging Growth Conference 82 Day 1 on May 21; Register to live stream
MIAMI, May 20, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 82nd Emerging Growth Conference on May 21 & 22, 2025. The Emerging Growth Conference identifies companies…
MTVA: Phase 1 Part 2 Data for DA-1726 in Obesity Expected Soon…
By David Bautz, PhD NASDAQ:MTVA READ THE FULL MTVA RESEARCH REPORT Business Update Data Expected in April 2025 from Part 2 of Phase 1 Trial of DA-1726 MetaVia Inc. (NASDAQ:MTVA) is currently conducting a Phase 1 clinical trial of DA-1726 i…